FDA NDC Directory · JSON-LD · Markdown

imatinib mesylate

NDC 0832-0532 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerUpsher-Smith Laboratories, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA212135
Dosage form / routeTABLET · ORAL
Active ingredientsIMATINIB MESYLATE (100 mg/1)
Marketing started20240517
Marketing ended20270131
Package count1

External sources

Source: openFDA. Public-domain (CC0).